Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

PURPOSE: The purpose of the study was to compare the outcomes of high-risk non-muscle-invasive bladder cancer (HR-NMIBC) patients treated with BCG vs recirculating hyperthermic intravesical chemotherapy (HIVEC) with mitomycin C (MMC). METHODS: A pilot phase II randomized clinical trial was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrero-Ramos, Félix, González-Padilla, Daniel A., González-Díaz, Alejandro, de la Rosa-Kehrmann, Federico, Rodríguez-Antolín, Alfredo, Inman, Brant A., Villacampa-Aubá, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994727/
https://www.ncbi.nlm.nih.gov/pubmed/35037963
http://dx.doi.org/10.1007/s00345-022-03928-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994727/
https://www.ncbi.nlm.nih.gov/pubmed/35037963
http://dx.doi.org/10.1007/s00345-022-03928-1

Ejemplares similares